Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
7,450
Bio-Rad Laboratories Inc News & Analysis
stocks
10 cheap wide-moat US stocks for 2025
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,182.20 | 66.50 | 0.73% |
| CAC 40 | 8,447.27 | 63.26 | 0.75% |
| DAX 40 | 24,910.41 | 16.40 | 0.07% |
| Dow JONES (US) | 51,999.67 | 328.64 | 0.64% |
| FTSE 100 | 10,494.21 | 63.59 | 0.61% |
| HKSE | 24,270.87 | 223.08 | -0.91% |
| NASDAQ | 26,376.34 | 307.60 | -1.15% |
| Nikkei 225 | 69,926.08 | 521.58 | 0.75% |
| NZX 50 Index | 13,408.32 | 17.81 | -0.13% |
| S&P 500 | 7,511.35 | 42.94 | -0.57% |
| S&P/ASX 200 | 8,965.40 | 64.60 | 0.73% |
| SSE Composite Index | 4,088.74 | 3.15 | -0.08% |